1. Inicio
  2. Proyectos y Estudios
  3. A Phase 1b, Open-label, Single-arm, Multicenter Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ELA026 in Adults and Adolescents with Secondary Hemophagocytic Lymphohistiocytosis (sHLH).

A Phase 1b, Open-label, Single-arm, Multicenter Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ELA026 in Adults and Adolescents with Secondary Hemophagocytic Lymphohistiocytosis (sHLH).

Datos básicos

ENSAYO CLÍNICO ELA026-CP002 2021-001387-20 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2022 Año de finalización: 2022

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

ELECTRA THERAPEUTICS

Cita

Compartir